InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Hardy Alexander. Insider active across 1 company, notably Biomarin Pharmaceutical INC. Aggregated, 8 filings have been logged. History available since 1 December 2023. The latest transaction was disclosed on 17 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Hardy Alexander is associated with Biomarin Pharmaceutical INC, where he is Chief Executive Officer. He has 8 filings in total, and across the 8 sampled recent filings from 2023-12-05 to 2026-03-19, the recorded amounts are all linked to tax withholding, with sum_buy_eur at 0 and sum_sell_eur at 0.